enGene Holdings Inc
For the period ended Oct 31, 2024. Filed Dec 19, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Dec 19, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| enGene Holdings Inc. | ||
| Date: December 19, 2024 | By: | /s/ Ronald H. W. Cooper |
|---|---|---|
| Name: Ronald H. W. Cooper | ||
| Title: Chief Executive Officer | ||
Pursuant to the requirements of the Securities Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Ronald H. W. Cooper | Chief Executive Officer and Director(Principal Executive Officer) | December 19, 2024 |
| Ronald H. W. Cooper | ||
| /s/ Ryan Daws | Chief Financial Officer(Principal Financial Officer and Principal Accounting Officer) | December 19, 2024 |
| Ryan Daws | ||
| /s/ Jasper Bos | Director | December 19, 2024 |
| Jasper Bos | ||
| /s/ Gerald Brunk | Director | December 19, 2024 |
| Gerald Brunk | ||
| /s/ Dr. Richard Glickman | Director | December 19, 2024 |
| Dr. Richard Glickman | ||
| /s/ Paul Hastings | Director | December 19, 2024 |
| Paul Hastings | ||
| /s/ Wouter Joustra | Director | December 19. 2024 |
|---|---|---|
| Wouter Joustra | ||
| /s/ Lota Zoth | Director | December 19, 2024 |
| Lota Zoth | ||
INDEX TO FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Balance Sheets as of October 31, 2024 and 2023 | F-3 |
| Consolidated Statements of Operations and Comprehensive Loss for the Years Ended October 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Redeemable Convertible Preferred Shares and Shareholders’ Equity (Deficit) for the Years Ended October 31, 2024 and 2023 | F-5 |
| Consolidated Statement of Cash Flows for the Years ended October 31, 2024 and 2023 | F-6 |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.